The blood platelet proteome is changed in UREMIC patients

Platelets

Volumn 18, Issue 5, 2007, Pages 386-388

  Walkowiak, Bogdan ^a,b   Kamińska, Marta ^a   Okrój, Wiesława ^a   Tański, Wojciech ^b   Sobol, Anna ^c   Zbróg, Zbigniew ^d   Przybyszewska Doroś, Iwona ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c N Barlicki University Hospital No 1 of Medical University of Lodz   (Poland)

^d Hemodialysis Unit   (Poland)

Author keywords

2D electrophoresis; Blood platelets; Hemodialysis; proteome; Uremia

Indexed keywords

PROTEOME;

ADULT; AGED; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THROMBOCYTE; TWO DIMENSIONAL ELECTROPHORESIS; UREMIA;

ADULT; AGED; BLOOD PLATELETS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; ISOELECTRIC POINT; MALE; MIDDLE AGED; PROTEOME; RENAL DIALYSIS; UREMIA;

EID: 34547181022     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100601095871     Document Type: Article

References (11)

1. Escolar G, Diaz-Ricart M, Cases A. Uremic platelet dysfunction: Past and present. Curr Hematol Rep 2005;4:359-367.
2. Moal V, Brunet P, Dou L, Morange S, Sampol J, Berland Y. Impaired expression of glycoproteins on resting and stimulated platelets in uremic patients. Nephrol Dial Transplant 2003;18:1834-1841.
3. Walkowiak B, Pawlowska Z, Michalak E, Cierniewski CS. Expression of fibrinogen receptors on platelets of uremic patients is correlated with the content of GPIIb and plasma level of creatinine. Thromb Haemost 1994;71:164-168.
4. Walkowiak B, Michalak E, Borkowska E, Koziolkiewicz W, Cierniewski CS. Concentration of RGDS containing products in uremic plasma is correlated with progression in renal failure. Thromb Res 1994;76:133-143.
5. Bazilinski N, Shaykh M, Dunea G, Mamdani B, Patel A, Czapek E, Ahmed S. Inhibition of platelet function by uremic middle molecules. Nephron 1985;40:423-428.
6. Berns JS, Mosenkis A. Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis. Hemodial Int 2005;9:7-22.
7. Aggarwal A, Kabbani SS, Rimmer JM, Gennari FJ, Taatjes DJ, Sobel BE, Schneider DJ. Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: A potential contributor to cardiovascular risk. Am J Kidney Dis 2002;40:315-322.
8. Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, Mischak H, Drueke TB, Lacour B, Massy ZA. Effects of oral vitamin C supplementation in hemodialysis patients: A proteomic assessment. Proteomics 2005;5:Dec 21, Epub ahead of print www.proteomicsjournal.com
9. Garcia A, Watson SP, Dwek RA, Zitzmann N. Applying proteomics technology to platelet research. Mass Spectrom Rev 2005;24:918-90.
10. Walkowiak B, Kralisz U, Michalec L, Majewska E, Koziolkiewicz W, Ligocka A, Cierniewski CS. Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. Thromb Res 2000;99:495-502.
11. ImageMaster™ 2D Elite Software, version 4.1, manual, cat. no. 18-1147-22 Rev. AB.